Press releases View full list

January 31, 2018

Invitae to participate in two upcoming investor conferences, including the 2018 BIO CEO & Investor Conference and Leerink Partners 7th Annual Global Healthcare Conference

SAN FRANCISCO, Jan. 31, 2018 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Sean George, chief executive officer of Invitae, will participate in two upcoming investor conferences being held in New York City.

Invitae's (NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people.  www.invitae.com (PRNewsFoto/Invitae Corporation)

Sean George will present at the 2018 BIO CEO & Investor Conference on Tuesday, February 13, 2018 at 10:00 a.m. Eastern / 7:00 a.m. Pacific. Additionally, Sean George will participate in a fireside chat at the Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, February 14, 2018 at 10:30 a.m. Eastern / 7:30 a.m. Pacific.

The live webcasts of both conference presentations may be accessed by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcasts will be available shortly after the conclusions of the presentations and will be archived on the company's website.

About Invitae
Invitae Corporation's (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics in clinical areas across all stages of life, Invitae is aggregating the world's genetic tests into a single service with better quality, faster turnaround time, and lower prices. The company provides a variety of diagnostic tests with clinical utility in preimplantation and carrier screening for inherited disorders, miscarriage analysis, pediatric and developmental disorders, neurological disorders, cardiovascular disorders, metabolic disorders, and hereditary cancers. For more information, visit our website at invitae.com.

Contact:
Kate McNeil
ir@invitae.com
347-204-4226

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/invitae-to-participate-in-two-upcoming-investor-conferences-including-the-2018-bio-ceo--investor-conference-and-leerink-partners-7th-annual-global-healthcare-conference-300590800.html

SOURCE Invitae Corporation

NYSE: NVTA 8.37 +0.06 +0.72% Volume: 322,915 20 minute delay July 17, 2018

Investor Toolkit

Feature Presentation

Email Alerts

Sign up to receive Invitae financial information by email.
Email Address: *
I'D LIKE TO RECEIVE EMAILS ABOUT: *




 
Enter the code shown above.

Investor Contact

1400 16th St.
San Francisco, CA, 94103
Email: ir@invitae.com